L. rhamnosus TB-02 and L. reuteri blend for a European women's-health brand — 10 billion CFU with published strain safety.
A women's-health brand in Europe needed a vaginal-support formula backed by strain-level science. We combined TB-02 with L. reuteri, documented epithelial adhesion data and delivered registration-ready safety files.
Key Features
10 billion CFU, 60-day course packaging
Strain adhesion data included in dossier
Feminine-health positioning with clinical citations
Registered in EU and Australia (TGA-listed)
Request a quote and our engineers will send you the full specification sheet, stability reports and free samples.